Alosetron
Back to searchMolecule Structure
Scientific Name
Alosetron
Description of the Drug
Alosetron is a 5-HT3 antagonist used to treat diarrhea-predominant IBS.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00969
http://www.drugbank.ca/drugs/DB00969
Brand Name(s)
Not Available
Company Owner(s)
Eywa Pharma Pte Ltd, Par Pharmaceutical Inc, Mankind Pharma Ltd, Amneal Pharmaceuticals Of New York Llc, Sebela Ireland Ltd, Hikma Pharmaceuticals Usa Inc, Rising Pharma Holdings Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Serotonin 3a (5-HT3a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1899 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL631 | ||
PharmGKB | PA164745502 | ||
Human Metabolome Database | HMDB0015104 | ||
DrugBank | DB00969 | ||
PubChem: Thomson Pharma | 14922649 | ||
PubChem | 2099 | ||
LINCS | LSM-5576 | ||
Nikkaji | J532.750D | ||
PDBe | S7Y | ||
BindingDB | 50014558 | 93624 | |
EPA CompTox Dashboard | DTXSID6044278 | ||
DrugCentral | 129 | ||
ChemicalBook | CB8149787 | ||
Guide to Pharmacology | 2296 | ||
rxnorm | ALOSETRON | LOTRONEX | ALOSETRON HYDROCHLORIDE |
ChEBI | 253342 | ||
ZINC | ZINC000013537284 |